Spinal 2-chloroprocaine: The effect of added clonidine

Anesthesia and Analgesia

Volumn 100, Issue 2, 2005, Pages 559-565

  Davis, Brad R ^a   Kopacz, Dan J ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; CHLOROPROCAINE; CLONIDINE; ROPIVACAINE;

ADULT; ANESTHESIA MECHANISM; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROSTIMULATION; FEMALE; HEMODYNAMICS; HOSPITAL DISCHARGE; HUMAN; MALE; MICTURITION; MOBILIZATION; NERVE BLOCK; NEUROTOXICITY; NORMAL HUMAN; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPINAL ANESTHESIA;

ADRENERGIC ALPHA-AGONISTS; ADULT; ANESTHESIA, SPINAL; ANESTHETICS, LOCAL; BLOOD PRESSURE; CLONIDINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ELECTRIC STIMULATION; FEMALE; HEART RATE; HUMANS; ISOMETRIC CONTRACTION; MALE; MIDDLE AGED; MOTOR NEURONS; MUSCLE, SKELETAL; NEURONS, AFFERENT; PAIN MEASUREMENT; PROCAINE;

EID: 12844274339     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000143381.30409.62     Document Type: Article

References (29)

1. Foldes F, McNall P. 2-Chloroprocaine: a new local anesthetic agent. Anesthesiology 1952;13:287-96.
2. Ravindran R, Bond V, Tasch M, et al. Prolonged neural blockade following regional analgesia with 2-chloroprocaine. Anesth Analg 1980;59:447-51.
3. Reisner L, Hochman B, Plumer M. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection. Anesth Analg 1980;59:452-4.
4. Moore D, Spierdijk J, van Kleef J, et al. Chloroprocaine neurotoxicity: four additional cases. Anesth Analg 1982;61: 155-9.
5. Wang BC, Hillman DE, Spielholz NI, Turndorf H. Chronic neurological deficits and Nesacaine-CE: an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984;63:445-7.
6. Gissen A, Datta S, Lambert D. The chloroprocaine controversy. Reg Anesth Pain Med 1984;9:124-45.
7. Kalichman M, Powell H, Reisner LS, Myers R. The role of 2-chloroprocaine and sodium bisulfite in rat sciatic nerve edema. J Neuropathol Exp Neurol 1986;45:566-75.
8. Taniguchi M, Bollen A, Drasner K. Sodium bisulfite: scapegoat for chloroprocaine neurotoxicity? Anesthesiology 2004;100: 85-91.
9. Yoos J, Kopacz D. Spinal 2-chloroprocaine for surgery: an initial 10-month experience. Anesth Analg 2005;100:553-8.
10. Palas T. 1% chloroprocaine for spinal anesthesia [abstract]. Reg Anesth Pain Med 2003;28:A52.
11. Schneider M, Ettlin T, Kaufmann M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993;76:1154-7.
12. Freedman J, Li D, Drasner K, et al. Risk factors for transient neurologic symptoms after spinal anesthesia. Anesthesiology 1998;89:633-41.
13. Smith K, Kopacz D. Spinal 2-chloroprocaine: a dose ranging study and the effect of added epinephrine. Anesth Analg 2004; 98:81-8.
14. Kouri M, Kopacz D. Spinal 2-chloroprocaine: a comparison with lidocaine in volunteers. Anesth Analg 2004;98:75-80.
15. Vath J, Kopacz D. Spinal 2-chloroprocaine: the effect of added fentanyl. Anesth Analg 2004;98:89-94.
16. Bonnet F, Brun Buisson V, Francois Y, et al. Effects of oral and subarachnoid clonidine on spinal anesthesia with bupivacaine. Reg Anesth Pain Med 1990;15:211-4.
17. De Kock M, Gautier P, Panard L, et al. Intrathecal ropivacaine and clonidine for ambulatory knee arthroscopy. Anesthesiology 2001;94:574-8.
18. Dobrydnjov I, Samarutel J. Enhancement of intrathecal lidocaine by addition of local and systemic clonidine. Acta Anaesthesiol Scand 1999;43:556-62.
19. Dobrydnjov I, Axelsson K, Thorn S-E, et al. Clonidine combined with small-dose bupivacaine during spinal anesthesia for inguinal herniorrhaphy: a randomized double-blinded study. Anesth Analg 2003;96:1496-503.
20. Niemi L. Effects of intrathecal clonidine on duration of bupivacaine spinal anaesthesia, haemodynamics, and postoperative analgesia in patients undergoing knee arthroscopy. Acta Anaesthesiol Scand 1994;8:724-8.
21. Petersen-Felix S, Zbinden A, Fischer M, et al. Isoflurane minimum alveolar concentration decreases during anesthesia and surgery. Anesthesiology 1993;79:959-65.
22. Barsa J, Batra M, Fink B, Sumi S. A comparative in vivo study of local neurotoxicity of lidocaine, bupivacaine, 2-chloroprocaine, and a mixture of 2-chloroprocaine and bupivacaine. Anesth Analg 1982;61:961-7.
23. Ford D, Raj P. Peripheral neurotoxicity of 2-chloroprocaine and bisulfite in the cat. Anesth Analg 1987;66:719-22.
24. Ready L, Plumer M, Haschke R, et al. Neurotoxicity of intrathecal local anesthetics in rabbits. Anesthesiology 1985;63:364-70.
25. Hersh EV, Condouris G, Havelin D. Actions of intrathecal chloroprocaine and sodium bisulfite on rat spinal reflex function utilizing a noninvasive technique. Anesthesiology 1990;72: 1077-82.
26. Feldman H, Covino B. A chronic model for investigation of experimental spinal anesthesia in the dog. Anesthesiology 1981; 54:148-52.
27. Rosen M, Baysinger C, Shnider S, et al. Evaluation of neurotoxicity after subarachnoid injection of large volumes of local anesthetic solutions. Anesth Analg 1983;62:802-8.
28. Li D, Bahar M, Cole G, Rosen M. Neurological toxicity of the subarachnoid infusion of bupivacaine, lignocaine, or 2-chloroprocaine in the rat. Br J Anaesth 1985;57:424-9.
29. Myers R, Kalichman M, Reisner L, Powell H. Neurotoxicity of local anesthetics: altered perineurial permeability, edema, and nerve fiber injury. Anesthesiology 1986;64:29-35.